SLDB — Solid Biosciences Inc

Ownership history in Vestal Point Capital, LP  ·  9 quarters on record

This page tracks every 13F SEC filing in which Vestal Point Capital, LP reported a position in Solid Biosciences Inc (SLDB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.48% (2024 Q3)
Avg. % of fund
0.8%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 5,815,000 +2,840,000 +95.5% 1.12% $32.8M $5.64
2025 Q3 ADDED 2,975,000 +1,470,000 +97.7% 0.83% $18.4M $6.17
2025 Q2 REDUCED 1,505,000 -248,558 -14.2% 0.39% $7.3M $4.87
2025 Q1 REDUCED 1,753,558 -1,096,442 -38.5% 0.46% $6.5M $3.70
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SLDB price (monthly, adj. close)

Other funds also holding SLDB

As of 2025 Q4 — sorted by position size

Monashee Investment Management LLC 3Y 7Y 4.29% Bain Capital Life Sciences Investors, LLC 3Y 7Y 3.42% Ally Bridge Group (NY) LLC 3Y 2.43% Birchview Capital, LP 3Y 7Y 2.33% Siren, L.L.C. 1.29% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.19% Redmile Group, LLC 3Y 7Y 0.77% Knott David M Jr 3Y 0.42% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.34% Nantahala Capital Management, LLC 3Y 7Y 0.3%
← Back to Vestal Point Capital, LP Holdings